Metropolis Healthcare’s board approves acquisition of Hitech Diagnostic Centre and its subsidiary

16 Oct 2021 Evaluate

Metropolis Healthcare’s board has approved the acquisition of Hitech Diagnostic Centre and its subsidiary Centralab Healthcare Services for a cash consideration of Rs 636 crore. The company's board had earlier approved the acquisition partly by cash consideration of Rs 511 crore and equity consideration of up to 4,95,000 fully paid-up equity shares of Rs 2 each.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

1927.75 15.95 (0.83%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6827.25
Max Healthcare Inst 1004.65
Narayana Hrudayalay 1815.85
Aster DM Healthcare 568.05
Global Health 1048.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×